1 January 2024 false No description of principal activity Taxfiler 2024.6 OC365419business:LimitedLiabilityPartnershipLLP2024-01-012024-12-31 OC3654192023-12-31 OC3654192024-01-012024-12-31 OC365419business:AuditExempt-NoAccountantsReport2024-01-012024-12-31 OC365419business:FilletedAccounts2024-01-012024-12-31 OC3654192024-12-31 OC365419business:PartnerLLP12024-01-012024-12-31 OC365419business:PartnerLLP22024-01-012024-12-31 OC365419business:RegisteredOffice2024-01-012024-12-31 OC3654192023-12-31 OC365419core:RetainedEarningsAccumulatedLosses2024-12-31 OC365419core:RetainedEarningsAccumulatedLosses2023-12-31 OC365419business:SmallEntities2024-01-012024-12-31 OC365419countries:EnglandWales2024-01-012024-12-31 OC3654192023-01-012023-12-31 iso4217:GBP xbrli:pure
Registered No. OC365419 (England and Wales)
Novator Pharma Llp Unaudited accounts for the year ended 31 December 2024
Novator Pharma Llp LLP Information for the year ended 31 December 2024
Designated members
Mr Shakhmir IADIGAROV
Mr Aytan YADIGAROVA
Registered Number
OC365419 (England and Wales)
Registered Office
Office 307, Regico Offices The Old Bank 153 The Parade High Street Watford WD17 1NA United Kingdom
- 2 -
Novator Pharma Llp Statement of financial position as at 31 December 2024
2024 
2023 
Notes
£ 
£ 
Current assets
Debtors
14,218,062 
10,910,042 
Cash at bank and in hand
154,735 
166,400 
14,372,797 
11,076,442 
Net current assets
14,372,797 
11,076,442 
Net assets attributable to members
14,372,797 
11,076,442 
Represented by:
Loans and other debts due to members
3
11,942,659 
10,998,803 
Members' other interests
Other reserves
2,430,138 
77,639 
14,372,797 
11,076,442 
Total members' interests
Loans and other debts due to members
11,942,659 
10,998,803 
Members' other interests
2,430,138 
77,639 
14,372,797 
11,076,442 
For the year ending 31 December 2024 the LLP was entitled to exemption under section 477 of the Companies Act 2006 (as applied to LLPs) relating to small LLPs.
The members acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 (as applied to LLPs) with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to LLPs subject to the small LLPs regime. The profit and loss account has not been delivered to the Registrar of Companies.
Approved by the members on 25 September 2025.
Mr Shakhmir IADIGAROV Designated member Limited Liability Partnership Registration No. OC365419
- 3 -
Novator Pharma Llp Notes to the Accounts for the year ended 31 December 2024
1
Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard) and the Statement of Recommended Practice (SORP), Accounting by Limited Liability Partnerships.
Presentation currency
The accounts are presented in £ sterling.
2
Statutory information
Novator Pharma Llp is a limited liability partnership, incorporated in England and Wales, registration number OC365419. Its registered office is Office 307, Regico Offices The Old Bank, 153 The Parade High Street, Watford, WD17 1NA, United Kingdom.
3
Loans and other debts due to members
2024 
2023 
£ 
£ 
Loans from members
11,942,659 
10,998,803 
Amounts falling due within one year
11,942,659 
10,998,803 
Loans and other debts due to members rank equally with debts due to other unsecured creditors in the event of a winding up.
4
Average number of employees
During the year the average number of employees was 0 (2023: 0).
- 4 -